Tag: Apellis

FDA, Regulations

Apellis wins FDA approval of first drug for type of vision loss

February 17, 2023

Via: Biopharma Dive

The Food and Drug Administration on Friday approved the first drug for a common and irreversible form of vision loss. Whether the medicine, developed by Apellis Pharmaceuticals, can safely help patients maintain their sight for longer isn’t yet clear, though, […]